Biology and therapeutic applications of peroxisome proliferator- activated receptors.
about
Cognitive remission: a novel objective for the treatment of major depression?Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerTang-Nai-Kang alleviates pre-diabetes and metabolic disorders and induces a gene expression switch toward fatty acid oxidation in SHR.Cg-Leprcp/NDmcr ratsHypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway.VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.Exposure of neonatal rats to maternal cafeteria feeding during suckling alters hepatic gene expression and DNA methylation in the insulin signalling pathwaySynthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agentsSingle-Nucleotide Polymorphism of PPARγ, a Protein at the Crossroads of Physiological and Pathological Processes.Recent advances in the investigation of pancreatic inflammation induced by large doses of basic amino acids in rodents.Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.Novel thiazole derivatives: a patent review (2008 - 2012. Part 2).Peroxisome-mitochondria interplay and disease.An update on PPAR activation by cannabinoids.Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors.The Peroxisome-Mitochondria Connection: How and Why?Effects of germinated brown rice and its bioactive compounds on the expression of the peroxisome proliferator-activated receptor gamma gene.Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1N-acylethanolamine acid amidase (NAAA), a new path to unleash PPAR-mediated analgesia.Training-induced anti-atherosclerotic effects are associated with increased vascular PPARgamma expression in apolipoprotein E-deficient mice.
P2860
Q26775386-6370A8E0-3734-4587-8386-C3898F9B0E42Q26829126-B95C906D-16B7-47E0-9FF4-7E29C570C4B2Q28546258-1B1ACF0D-8164-475C-AC58-26F9FE7C5311Q33624829-197D5954-E872-4212-A2DE-FD91ECE66BE5Q34428997-6BEFAC61-18C3-4806-BE19-ACDC3B0546F3Q35072290-8233D75C-A81A-4BDB-ACD6-08DD5E52A648Q37258925-8A13829D-BD36-48F3-A41E-09408EB61CA6Q37690874-5D94AA92-970A-43C0-A046-8A0DF90015DBQ38173611-F38F6488-D135-4240-B010-A24BF00B33AAQ38184546-68AC6C31-F885-429A-BF83-DC3B771CE0E0Q38205485-11A6E106-7BB4-4BFE-A328-0994EDE628A7Q38357539-782F1F0E-3845-47BA-BFDD-74E87750C2A7Q38808034-964211F0-5EC6-434E-A948-909BE72E8A10Q38992589-78EBDF4D-D835-4620-8B39-455571971703Q39326795-9AF8BE53-8859-428C-AA4C-DC7A906C73C1Q40073832-4723EB41-51E7-4952-963A-A73538E1ECCAQ42150000-8331BF45-7B45-452D-8B27-FFD785AAEE2CQ42657017-A2575003-42CB-4ADD-9A25-2271ED78CC7DQ53311171-84F85EDA-7DA1-47C4-8AF3-1646DAF2F900
P2860
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
@en
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
@nl
type
label
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
@en
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
@nl
prefLabel
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
@en
Biology and therapeutic applications of peroxisome proliferator- activated receptors.
@nl
P1476
Biology and therapeutic applications of peroxisome proliferator- activated receptors
@en
P2093
Maria P Menendez-Gutierrez
P304
P356
10.2174/156802612799436669
P577
2012-01-01T00:00:00Z